Raya’s pipeline ALS drug shows early signs of efficacy in Phase II trial

Raya’s pipeline ALS drug shows early signs of efficacy in Phase II trial

Source: 
Clinical Trials Arena
snippet: 

Raya Therapeutics said that it will initiate more amyotrophic lateral sclerosis (ALS) trials in 2025 following the investigator-led Phase II trial data.